Injective [INJ] has seen a significant boost following the launch of regulated Injective Futures in the United States, marking a key step in its institutional adoption. The listing on Bitnomial, a CFTC-regulated exchange, has contributed to a 20% rise in open interest, indicating increased market participation. Concurrently, INJ's price has surged over 10% in the past 24 hours, breaking the $3.33 resistance level. The recent community buyback, which removed 51,000 INJ from circulation, has eased supply-side pressure, further supporting the bullish trend. As momentum builds, the next target is the $4.0 liquidity zone, a critical psychological threshold. The combination of regulated futures access, reduced supply, and rising open interest suggests continued bullish momentum, with institutional activity playing a pivotal role in this upward trajectory.